Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?

類似資料

• Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy
  著者:: Zhang, Lu, 等
  出版事項: (2015)
• Prognostic Value of Plasma Epstein–Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
  著者:: Chen, Wen-Hui, 等
  出版事項: (2016)
• Future of Radiotherapy in Nasopharyngeal Carcinoma
  著者:: Sun, Xue-Song, 等
  出版事項: (2019)
• The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
  著者:: Guo, Shan-Shan, 等
  出版事項: (2015)
• Elevated High-Sensitivity C-Reactive Protein Levels Predict Decreased Survival for Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
  著者:: Tang, Lin Quan, 等
  出版事項: (2015)